About
Triomab Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
97
By Phase
PHASE1: 1NA: 1
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04819399Lead Sponsor
Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
PHASE1Unknown
30 participants
Started: Jul 7, 2020 · Completed: Dec 30, 2023
NCT03850106Collaborator
Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations
NACompleted
67 participants
Started: Jul 11, 2018 · Completed: Apr 30, 2019
Locations (1)
Headquarters
Puchheim, Germany
Map
Loading map...